Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable GIST

Dagher R, Cohen M, Williams G, Rothmann M, Gobburu J, Robbie G, Rahman A, Chen G, Staten A, Griebel D, Pazdur R.
Clin Cancer Res. 2002 Oct;8(10):3034-8.
PMID: 12374669
This is the FDA approval summary for Gleevec in metastatic/unresectable GIST.
free full-text access in PubMed.
Entrez PubMed